Discipline | Medicine |
---|---|
Language | English |
Edited by | João Monteiro |
Publication details | |
History | 1995–present |
Publisher | |
Frequency | Monthly |
58.7 (2023) | |
Standard abbreviations | |
ISO 4 | Nat. Med. |
Indexing | |
CODEN | NAMEFI |
ISSN | 1078-8956 (print) 1546-170X (web) |
LCCN | 95660642 |
OCLC no. | 471508019 |
Links | |
Nature Medicine is a monthly peer-reviewed medical journal published by Nature Portfolio covering all aspects of medicine. It was established in 1995. The journal seeks to publish research papers that "demonstrate novel insight into disease processes, with direct evidence of the physiological relevance of the results". [1] As with other Nature journals, there is no external editorial board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process. The editor-in-chief is João Monteiro. [2]
According to the Journal Citation Reports , the journal has a 2021 impact factor of 58.7, ranking it 1st out of 296 journals in the category "Biochemistry & Molecular Biology". [3]
Nature Medicine is abstracted and indexed in: [4]
BioEssays is a monthly peer-reviewed review journal covering molecular and cellular biology. Areas covered include genetics, genomics, epigenetics, evolution, developmental biology, neuroscience, human biology, physiology, systems biology, and plant biology. The journal also publishes commentaries on aspects of science communication, education, policy, and current affairs.
Nature Chemical Biology is a monthly peer-reviewed scientific journal published by Nature Portfolio. It was established in June 2005 by founding Chief Editor Terry L. Sheppard as part of Nature Publishing Group. Sheppard was the Chief Editor of the journal 2004–2022. The current editor-in-chief is Russell Johnson.
The Journal of Biological Chemistry (JBC) is a weekly peer-reviewed scientific journal that was established in 1905. Since 1925, it is published by the American Society for Biochemistry and Molecular Biology. It covers research in areas of biochemistry and molecular biology. The editor is Alex Toker. As of January 2021, the journal is fully open access. In press articles are available free on its website immediately after acceptance.
The Journal of Molecular Recognition is a monthly peer-reviewed scientific journal publishing original research papers and reviews describing molecular recognition phenomena in biology. The current editor-in-chief is Marc H. V. van Regenmortel. It was established in 1988 and is published by John Wiley & Sons.
The Journal of Peptide Science is a monthly peer-reviewed scientific journal, published since 1995 by John Wiley & Sons on behalf of the European Peptide Society. The current editor-in-chief is Paolo Rovero.
Biotechnology and Applied Biochemistry is a bimonthly peer-reviewed scientific journal covering biotechnology applied to medicine, veterinary medicine, and diagnostics. Topics covered include the expression, extraction, purification, formulation, stability, and characterization of both natural and recombinant biological molecules. It is published by Wiley-Blackwell on behalf of the International Union of Biochemistry and Molecular Biology. The editors-in-chief are Gianfranco Gilardi and Jian-Jiang Zhong.
Nature Structural & Molecular Biology is a monthly peer-reviewed scientific journal publishing research articles, reviews, news, and commentaries in structural and molecular biology, with an emphasis on papers that further a "functional and mechanistic understanding of how molecular components in a biological process work together".
FEBS Letters is a not-for-profit peer-reviewed scientific journal published on behalf of the Federation of European Biochemical Societies (FEBS) by Wiley. It covers all aspects of molecular biosciences, including molecular biology and biochemistry. The aim of the journal is to publish primary research in the form of Research Articles, Research Letters, Communications and Hypotheses, as well as secondary research in the form of Review articles. The journal also publishes a News and Views column called "The Scientists' Forum". The editorial office of FEBS Letters is based in Heidelberg, Germany. The journal income is reinvested in science.
Archives of Biochemistry and Biophysics is a biweekly peer-reviewed scientific journal that covers research on all aspects of biochemistry and biophysics. It is published by Elsevier and as of 2012, the editors-in-chief are Paul Fitzpatrick, Helmut Sies, Jian-Ping Jin, and Henry Jay Forman.
The Journal of Biochemistry is a peer-reviewed scientific journal that covers research on biochemistry, molecular biology, cell biology, and biotechnology. It was established in 1922 and is published by Oxford University Press on behalf of the Japanese Biochemical Society. The editor-in-chief is Kohei Miyazono. According to the Journal Citation Reports, the journal has a 2020 impact factor of 3.387.
Molecular & Cellular Proteomics is a monthly peer-reviewed scientific journal established in 2002 and published by the American Society for Biochemistry and Molecular Biology. It covers research on structural and functional properties of proteins, especially with regard to development.
Oncogene is a peer-reviewed scientific journal published under the Nature Portfolio addressing cancer cell genetics and the structure and function of oncogenes. The journal has editorial office in London, England under the publishing company Springer Nature. The journal was established in 1987. An open access online-only sister journal, Oncogenesis, was established in 2012 by Douglas R. Green, who was then Oncogene's editor-in-chief.
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. Another priority for Clinical Cancer Research is laboratory and animal studies of new drugs as well as molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. The journal is published by the American Association for Cancer Research.
Biological Chemistry is a peer-reviewed scientific journal focusing on biological chemistry. The journal is published by Walter de Gruyter and the current editor-in-chief is Bernhard Brüne.
Nature Communications is a peer-reviewed, open access, scientific journal published by Nature Portfolio since 2010. It is a multidisciplinary journal that covers the natural sciences, including physics, chemistry, earth sciences, medicine, and biology. The journal has editorial offices in London, Berlin, New York City, and Shanghai.
MedChemComm is a peer-reviewed scientific journal publishing original (primary) research and review articles on all aspects of medicinal chemistry, including drug discovery, pharmacology and pharmaceutical chemistry. Until December 2019, it was published monthly by the Royal Society of Chemistry in partnership with the European Federation for Medicinal Chemistry, of which it was the official journal. Authors can elect to have accepted articles published as open access. According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.495, ranking it 27th out of 59 journals in the category "Chemistry, Medicinal" and 163 out of 289 journals in the category "Biochemistry & Molecular Biology".
Frontiers Media SA is a publisher of peer-reviewed, open access, scientific journals currently active in science, technology, and medicine. It was founded in 2007 by Kamila and Henry Markram. Frontiers is based in Lausanne, Switzerland, with offices in the United Kingdom, Spain, and China. In 2022, Frontiers employed more than 1,400 people, across 14 countries. All Frontiers journals are published under a Creative Commons Attribution License.
Glia is a monthly peer-reviewed scientific journal covering research on the structure and function of neuroglia. It was established in 1988 and is published by John Wiley & Sons. The founding and current editors-in-chief are Bruce R. Ransom and Helmut Kettenmann.
Experimental & Molecular Medicine is a monthly peer-reviewed open access medical journal covering biochemistry and molecular biology. It was established in 1964 as the Korean Journal of Biochemistry or Taehan Saenghwa Hakhoe Chapchi and published bi-annually. It was originally in Korean becoming an English-language journal in 1975. In 1994 the journal began publishing quarterly. It obtained its current name in 1996 at which time it also began publishing bi-monthly, switching to monthly in 2009. It is the official journal of the Korean Society for Biochemistry and Molecular Biology. The editor-in-chief is Dae-Myung Jue. It is published by the Nature Publishing Group. The full text of the journal from 2008 to the present is available at PubMed Central.
Experimental Parasitology is a monthly peer-reviewed scientific journal covering the field of parasitology. It is published by Elsevier and was established in 1951. The main topics covered are the physiology, immunology, biochemistry, and molecular biology of eukaryotic parasites, and the interaction between the parasite and its host, including chemotherapy against parasites. The editors-in-chief are Anton Aebischer and Bernd Kalinna.